Helicobacter pylori

Phathom Voquenza

Pharma

FDA signs off on Phathom's Voquezna for 2 stomach disorders

In a span of three days, Phathom Pharmaceuticals has scored two green lights from the FDA for its first-in-class heartburn drug Voquezna.

Kevin Dunleavy Nov 2, 2023 4:03pm

graphic of the intestines

Phathom to resubmit applications for Voquezna in coming months

Apr 4, 2023 10:07am

stomach

Takeda spinout Phathom clinches FDA twin nods, capital infusion

May 4, 2022 11:12am